Liposomal Applications to Cancer Therapy
- 1 April 1993
- journal article
- research article
- Published by SAGE Publications in Journal of Bioactive and Compatible Polymers
- Vol. 8 (2) , 158-177
- https://doi.org/10.1177/088391159300800205
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Liposomal modification with uronate, which endows liposomes with long circulation in vivo, reduces the uptake of liposomes by J774 cells in vitroLife Sciences, 1992
- Tumor accumulation of novel RES-avoiding liposomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in miceCancer Immunology, Immunotherapy, 1991
- Glucuronate-modified liposomes with prolonged circulation time.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Therapeutic effect of recombinant human tumor necrosis factor in ovarian carcinoma xenograft in nude miceGynecologic Oncology, 1989
- Activation of murine kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptideHepatology, 1988
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Pharmacokinetics and metabolism of muramyl dipeptide and nor-muramyl dipeptide [3H-labelled] in the mouseInternational Journal of Immunopharmacology, 1984
- A murine ovarian tumor with unique metastasizing capacityPublished by Elsevier ,1981
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979